Hypertension pulmonaire : physiopathologie et innovation thérapeutique
- World rank, all time
- #29,344 of 42,892
- Rank in France
- #1,684 of 2,321
- Research works
- 152 ▲ 80% vs 2013–17
- Citations
- 3.2k 21.0 per fractional work
- Top-10% rate
- 20.3% record average 16.5%
- Open access
- 47% world 28%
What does Hypertension pulmonaire : physiopathologie et innovation thérapeutique specialise in?
Where its research is concentrated relative to its size: Medicine takes 3.8× the share of its output that it takes of world research.
- MedicineField · 30.5 works3.8×
- Health SciencesDomain · 31.3 works3.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.
- Medicine 3.8×
- Neuroscience 2.1×
- Psychology 1.7×
- Immunology and Microbiology 1.4×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Health Professions 0.8×
- Environmental Science 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Nursing 0.3×
- Engineering 0.3×
- Agricultural and Biological Sciences 0.1×
- Chemistry 0.1×
- Materials Science 0.1×
- Mathematics 0.1×
- Social Sciences 0.1×
- Physics and Astronomy 0.0×
Which keywords describe research at Hypertension pulmonaire : physiopathologie et innovation thérapeutique?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Echocardiography, Endothelial Dysfunction, Pulmonary Hypertension, Chronic Kidney Disease, Treatment Guidelines, Right Heart Assessment, Survival Prediction and Heart Failure.
- Rejection
- Lung Transplant
- Treatment
- Congenital Heart Disease
- Thrombosis
- Risk Factors
- Chamber Quantification
- Oxidative Stress
- Obesity
- Epidemiology
- Diagnosis
- Heart Failure
- Right Heart Assessment
- Chronic Kidney Disease
- Endothelial Dysfunction
- Echocardiography
- Pulmonary Hypertension
- Treatment Guidelines
- Survival Prediction
- Management
- Mental Health
- Inflammation
- Cardiovascular Risk
- Cardiovascular Disease
- Diastolic Function
- Fibrosis
- Cancer
- Immunosuppressive Therapy
- Endovascular Repair
- Neurodevelopmental Outcomes
- Transplantation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 31 words, with their numbers
- Echocardiography10▲ 83×6 topics
- Endothelial Dysfunction8▲ 80×6 topics
- Pulmonary Hypertension8▲ 126×3 topics
- Chronic Kidney Disease7▲ 71×6 topics
- Treatment Guidelines7▲ 77×4 topics
- Right Heart Assessment7▲ 410×1 topic
- Survival Prediction7▲ 410×1 topic
- Heart Failure3▲ 18×8 topics
- Management2▲ 6.3×11 topics
- Diagnosis2▲ 5.2×12 topics
- Mental Health2▲ 3.2×5 topics
- Epidemiology2◆ 1.11×20 topics
- Inflammation2▲ 2.1×21 topics
- Obesity2▲ 5.5×2 topics
- Cardiovascular Risk2▲ 12×2 topics
- Oxidative Stress2▲ 2.3×13 topics
- Cardiovascular Disease2▲ 3.2×9 topics
- Chamber Quantification2▲ 45×1 topic
- Diastolic Function2▲ 45×1 topic
- Risk Factors2▲ 3.3×7 topics
- Fibrosis1▲ 17×6 topics
- Thrombosis1▲ 11×4 topics
- Cancer1▲ 2.1×14 topics
- Congenital Heart Disease1▲ 34×2 topics
- Immunosuppressive Therapy1▲ 15×2 topics
- Treatment1▲ 2.4×13 topics
- Endovascular Repair1▲ 30×3 topics
- Lung Transplant1▲ 75×1 topic
- Neurodevelopmental Outcomes1▲ 13×4 topics
- Rejection1▲ 59×1 topic
- Transplantation1▲ 24×3 topics
Which research topics does Hypertension pulmonaire : physiopathologie et innovation thérapeutique publish most on?
By volume in 2022–2025: Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Transplantation: Methods and Outcomes and Congenital Heart Disease Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 7 works
- 2 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 2 works
- 3 Transplantation: Methods and Outcomes Surgery 1 works
- 4 Congenital Heart Disease Studies Epidemiology 1 works
- 5 Mechanical Circulatory Support Devices Biomedical Engineering 1 works
- 6 Psychoanalysis and Psychopathology Research Clinical Psychology 1 works
- 7 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
- 8 Hemodynamic Monitoring and Therapy Surgery 1 works
- 9 Health, Medicine and Society General Health Professions 1 works
- 10 Ion Channels and Receptors Sensory Systems 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Hypertension pulmonaire : physiopathologie et innovation thérapeutique's research output changed?
Output in 2018–2022 was 80% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Le Plessis-Robinson
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.